explore -WSS

explore

author：leisure time 2025-09-28 23:47:11 - browse：7975

Why are addiction treatments so hard to get? Can small companies compete in obesity? And since when is “Series E” a thing in biotech?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. For the entirety of the opioid overdose epidemic, the U.S. has had readily available tools that are proven to save lives. STAT’s Lev Facher joins us to explain his reporting on why virtually every sector of American society is standing in the way of their use. We also discuss the latest news in the life sciences, including the haves and have-nots of venture capital, and the race to develop effective oral treatments for obesity.

For more on what we cover, here’s the story on addiction medicine; here’s the latest on biotech financing; here’s more on Novo Nordisk’s oral obesity treatment; here’s where you can find episodes of Color Code; here’s where you can subscribe to the First Opinion Podcast; and here’s where you can subscribe to our biotech newsletter, The Readout.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Jerome Adams on the need for new antivirals for Covid
Next article： Harvard's David Sinclair gets blowback over aging

WSS

He's 19 months old and has one of the world’s rarest diseases

BIO: Crackdown on China pharma industry would threaten U.S. drug supply

MassMutual is introducing free genetic testing for members

Families look for replacement for GSK asthma drug Flovent

Why Talkspace is targeting Medicare, a tricky market

Florida health officials providing scant details on measles cases

Wikipedia

explore

knowledge

How one medical school became remarkably diverse

H5N1 bird flu virus started spreading in cows in Texas in December

Alkermes shareholders re

Longer MASH drug regimen improved liver, Akero study finds

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Bird flu in milk supply is likely coming from asymptomatic cows

Tori Bowie and the unacceptable rates of Black maternal death

Medicare drug price negotiation continues, as pharma counteroffers

Medical leaders decry Supreme Court decision on affirmative action

Exact Sciences stock tumbles despite strong cancer detection sales

focus

For AI in health care standards, federal regulators join with industry group

He's 19 months old and has one of the world’s rarest diseases

Getting Alzheimer's drug Leqembi to patients can be a challenge

Ancient Greek ideas underpin modern concepts of pregnancy

MultiPlan and major insurers sued for alleged medical price

Medicare drug price negotiation continues, as pharma counteroffers

hotspot

leisure time

leisure time

Wikipedia